Dr. Amit Kumar (Pediatric-Oncology)

Consultant - Pediatric Hematology and Oncology Medical and Haemato Oncology , Cancer Institute



Hematological Malignancies

Pediatric Solid Tumors

Immunotherapy and Intrathecal Chemotherapy

Dr. Amit Kumar is Consultant, Paediatric haematology & oncology at Jaiprabha Medanta Superspeciality Hospital, Patna He pursued Fellowship in Paediatric Oncology from the prestigious Tata Memorial Centre, Mumbai. Before joining Medanta he was associated with B J Wadia Hospital for Children and HCG Cancer Centres, Mumbai as Consultant in Paediatric Haematology and Oncology.

With over 13 years of experience in Paediatrics and Paediatric Haematology and Oncology, his areas of interest include all kind of haematological cancers like ALL, AML, APML, CML, Lymphomas, LCH, HLH, etc.) and solid tumors like Ewing’s Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Hepatoblastoma, Wilm’s Tumour, Neuroblastoma and Brain Tumors like Medulloblastoma, Ependymoma, Gliomas, etc as well as Benign hematological disorders like Thalassemia, Sickle Cell Disease, Immune Thrombocytopenia, AIHA, etc.

Medical Qualifications

HBNI Fellowship in Pediatric OncologyTata Memorial Centre, Mumbai -
MD PediatricsPatna Medical College, Patna -
MBBSSCB Medical College, Cuttac -

Specialization and Expertise

  • Pediatric Blood Cancer ( ALL, AML, CML, JMML, APML, HLH, LCH)
  • Pediatric Lymphomas ( Hodgkin's, NHL, Burkitt's, ALCL, DLBCL)
  • Solid Tumors ( Neuroblastoma, Ewing's Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Wilm's, Retinoblastoma, Hepatoblastoma etc)
  • Cellular and Targeted Therapy
  • Immunotherapy
  • High Dose Chemotherapy
  • Benign Hematological diseases
  • Anemia, Thalassemia, Sickle cell Anemia, Aplastic Anemia, AIHA etc
  • Bleeding disorders ( ITP, vWD, Hemophilia, TTP, etc.)

Memberships & Certifications

  • Indian Academy of Pediatrics
  • National Neonatology Forum 
  • IAP- PHO Chapter
  • ASCO membership
  • Association of Medical Consultants, Mumbai

Awards & Accomplishments

  • Got First Prize in Paper presentation in Poster Category at SIOP ASIA 2020 conference on topic: "Effectiveness of oral metronomic chemotherapy as a bridge to high dose chemotherapy in AML presenting with fungal pneumonia AND /OR MDR BUG in rectal swab", 2020


  • :   Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1): An Experience from a Tertiary Care Center in North India (Indian J Pediatr (2010) 77:981–985),
  • :   Effectiveness of oral metronomic chemotherapy as a bridge to high dose chemotherapy in AML presenting with fungal pneumonia AND /OR MDR BUG in rectal swab; October 2020; Pediatric Hematology Oncology Journal 5(4) DOI: 10.1016/j.phoj.2021.04.094,
  • :   Teleconsultation in pediatric hematology-oncology practice – Dawning of a new era December 2021 Pediatric Hematology Oncology Journal 6(4):S65 DOI: 10.1016/j.phoj.2022.03.170,
  • :   Ghosal hematodiaphyseal dysplasia- Rare cause of refractory anemia;December 2021; Pediatric Hematology Oncology Journal 6(4):S41 DOI: 10.1016/j.phoj.2022.03.103,
  • :   Transcranial doppler screening in patients with sickle cell anemia in tertiary care hospital; December 2021;Pediatric Hematology Oncology Journal 6(4):S45-S46 DOI: 10.1016/j.phoj.2022.03.114,
  • :   Baseline nutrition in pediatric cancer therapy: A potential game changer December 2021 Pediatric Hematology Oncology Journal 6(4):S57 DOI: 10.1016/j.phoj.2022.03.145,
  • :   Blood stream infections in pediatric oncology patients in a tertiary care setup; December 2021;Pediatric Hematology Oncology Journal 6(4):S57 DOI: 10.1016/j.phoj.2022.03.146,
  • :   Clinico-hematological profile of pediatric acute megakaryoblastic leukemia - Single center experience; December 2021;Pediatric Hematology Oncology Journal 6(4):S30-S31 DOI: 10.1016/j.phoj.2022.03.077,